Molecules found in tarantula venom could offer a new treatment option for people living with Type 2 diabetes. The early-stage research, presented at the Diabetes
A pharmaceutical company has announced positive results from its phase Ib clinical study on its drug for neuropathic pain. AlzeCure develops a broad portfolio of
Approximately 9 in 10 specialists agree that people with Type 2 diabetes whose healthcare professionals (HCPs) collaborate tend to have better outcomes than those whose
According to researchers, blood glucose levels in young people with Type 1 diabetes improved during Britain’s first national lockdown in 2020. The team compared how
A landmark trial shows that an immunotherapy drug can delay Type 1 diabetes by an average of three years. Previously, in 2019, researchers from the
JDRF Impact Report 2020-21 JDRF has published its latest annual report highlighting the charities achievements. The Impact Report 2019-2020 explains how the Type 1 diabetes
Research has shown that losing just two to three kilograms (KGs) of weight and exercising for two years almost halves the risk of developing Type
Join JDRF on Thursday 11 February for a spectacular online event to mark 100 years since the discovery of insulin and raise money for the
Alopecia UK has joined the Connect Immune Research initiative, alongside founding members JDRF, MS Society, Versus Arthritis, and supporting partner the British Society for Immunology.
Welcome to the Academy! A new Diabetes Technology Network (DTN) education programme, initially for HCPs, has launched. Simply called Academy, it is bringing info on
